Paper3759976
Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin.
Yamagata M and 4 others. J Biol Chem, 1986. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. Papers, record 3759976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3759976
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chondroitin Sulfate Proteoglycans | Major topic |
| Fibronectins | Major topic |
| Hyaluronic Acid | Major topic |
| Proteoglycans | Major topic |
| Animals | |
| Binding, Competitive | |
| Chick Embryo | |
| Fibroblasts | |
| Humans | |
| Kinetics | |
| Molecular Weight | |
| Protein Binding | |
| Structure-Activity Relationship | |
| Tritium |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39930232 | Expression of Versican in the Retina and Its Implication in Retinal Disease. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/39930232 | PubMed |
| 37399500 | V3: an enigmatic isoform of the proteoglycan versican. | Am J Physiol Cell Physiol | 2023 | https://conductscience.org/library/papers/37399500 | PubMed |
| 35649251 | Defining the versican interactome in lung health and disease. | Am J Physiol Cell Physiol | 2022 | https://conductscience.org/library/papers/35649251 | PubMed |
| 33149218 | Distinct effects of different matrix proteoglycans on collagen fibrillogenesis and cell-mediated collagen reorganization. | Sci Rep | 2020 | https://conductscience.org/library/papers/33149218 | PubMed |
| 32623942 | Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity. | J Histochem Cytochem | 2020 | https://conductscience.org/library/papers/32623942 | PubMed |
| 31623299 | Exploring the Molecular Crosstalk between Pancreatic Bud and Mesenchyme in Embryogenesis: Novel Signals Involved. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31623299 | PubMed |
| 30814516 | Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis. | Nat Commun | 2019 | https://conductscience.org/library/papers/30814516 | PubMed |
| 30287763 | Role of Extracellular Matrix in Development and Cancer Progression. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30287763 | PubMed |
| 26951084 | Kinetics of versican-expressing macrophages in bone marrow after cord blood stem cell transplantation for treatment of acute myelogenous leukaemia. | J Clin Pathol | 2016 | https://conductscience.org/library/papers/26951084 | PubMed |
| 26755884 | Proteoglycans in liver cancer. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26755884 | PubMed |
| 24401530 | Versican and the regulation of cell phenotype in disease. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24401530 | PubMed |
| 24301295 | Bone marrow-derived endothelial progenitor cells protect postischemic axons after traumatic brain injury. | J Cereb Blood Flow Metab | 2014 | https://conductscience.org/library/papers/24301295 | PubMed |
| 24213471 | Therapeutic targeting of hyaluronan in the tumor stroma. | Cancers (Basel) | 2012 | https://conductscience.org/library/papers/24213471 | PubMed |
| 24180670 | CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion. | BMC Cancer | 2013 | https://conductscience.org/library/papers/24180670 | PubMed |
| 22862967 | The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis. | BMC Cancer | 2012 | https://conductscience.org/library/papers/22862967 | PubMed |
| 22393310 | Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican. | Int J Biol Sci | 2012 | https://conductscience.org/library/papers/22393310 | PubMed |
| 21079779 | Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling. | PLoS One | 2010 | https://conductscience.org/library/papers/21079779 | PubMed |
| 20730861 | Versican G1 domain and V3 isoform overexpression results in increased chondrogenesis in the developing chick limb in ovo. | Anat Rec (Hoboken) | 2010 | https://conductscience.org/library/papers/20730861 | PubMed |
| 20164174 | Impairment of embryonic cell division and glycosaminoglycan biosynthesis in glucuronyltransferase-I-deficient mice. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20164174 | PubMed |
| 20060370 | Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. | Mol Oncol | 2010 | https://conductscience.org/library/papers/20060370 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3759976
GET https://conductscience.org/api/papers/v1/3759976/cited_by?page=2